Buckley Ventures
Assembly Line
Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth
Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC.
The funding will accelerate the manufacturing and distribution of Mytos’ automated cell production system to more biotech and pharma companies to meet growing demand. The company’s platform is already in use by a number of life sciences companies globally. Mytos also has plans to expand its sales and development team